AzTrials
AzTrials

Sexual IntercourseRS-PPNCT07440082

Resumption of Sexual Intercourse in the Postpartum Period: Women's Experiences

An observational study of Sexual Intercourse, run by Université de Reims Champagne-Ardenne at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Sexual health, according to the World Health Organization (WHO), is a state of overall well-being related to sexuality. In the postpartum period, sexual health is often affected by hormonal, physical, and psychological changes. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Sexual Intercourse
What is being tested?
data collection
How many people
80 participants
Where
1 siteFrance
Study dates
22 Nov 2025to 22 Jan 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: women aged 18 and over, with a partner who gave birth more than 3 months and less than 6 months ago, regardless of the mode of delivery, whether or not they have resumed sexual intercourse since giving birth

Who may be able to join

  • Women who gave birth between 3 and 6 months prior to participating in the study
  • Whether or not they have resumed sexual intercourse.
  • With a partner.
  • Aged 18 years or older
  • Agreeing to participate in the study.

Who cannot join

  • Women who were pregnant at the time of the study
  • Who had experienced perinatal bereavement
  • Who were protected by law (guardianship, curatorship, judicial protection)

Trial locations and contacts

1 site in 1 country.

France1 site
  • Ufr Medecine Urca

    Reims, 51100

Other trials in France

About this study

Sexual health, according to the World Health Organization (WHO), is a state of overall well-being related to sexuality. In the postpartum period, sexual health is often affected by hormonal, physical, and psychological changes. Up to 83% of women report sexual difficulties within the first three months after childbirth, and these issues may persist for up to a year. Dyspareunia is one of the most common symptoms, affecting approximately 35% of postpartum women. Other difficulties include vaginal dryness, fatigue, decreased libido, and fear of pain. Breastfeeding and perineal trauma are known to influence the resumption of sexual activity.

Health professionals may lack training or confidence in addressing sexual health, often leaving women to cope with their difficulties alone, even though they express a need for information and support. In this context, it is essential to better understand the difficulties women face when resuming sexual activity after childbirth, in order to improve the detection and management of sexual health disorders.

Read the detailed description

Objectives Primary: To describe the resumption of sexual activity within the first 3 months postpartum, including any potential difficulties encountered.

Being tested
data collection
Keywords
sexual intercourse, postpartum, women
Medical subject headings
Coitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • data collectionOther

    data collection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Questionnaire on the resumption of sexual intercourse in the postpartum period

    Proportion of participants who resumed sexual intercourse within the 3 months following childbirth

    Measured: Day0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2026
  2. Study start22 Nov 2025
  3. Primary completion22 Jan 2026
  4. Study completion22 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07440082
Sponsor's protocol ID
2025_RIPH_11_SF_N Painvin
Acronym
RS-PP
Status last verified
Feb 2026
First submitted
12 Feb 2026
Last updated
27 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Sexual Intercourse, run by Université de Reims Champagne-Ardenne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Questionnaire on the resumption of sexual intercourse in the postpartum period (time frame: Day0). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2026; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in